New approaches, such as partnerships between public research institutions and private industry, are needed. While clinical trials of the most promising drugs and vaccines need to be pursued, we also need to go back to the drawing board and develop entirely new tactics.
前路仍然漫长，加速新药品和疫苗的研发离不开增加资金支持。不幸的是，开发新肺结核干预方法的私人部门激励太弱了。必须依靠新的新方法，如公共研究机构和私人企业的合作。我们需要对大部分潜在高效药品和疫苗进行临床测试，也需要重新规划蓝图，构想新的策略。